Novartis and Roche's big-selling eye drug Lucentis has its first biosimilar competitor in Europe, after the European Commission approved Samsung Bioepis' copycat drug Byooviz. Byooviz (ranibizumab ...

Lucentis was first approved in the US in 2007 for wet AMD and grew quickly thereafter thanks to a string of additional indications, including DMO, myopic choroidal neovascularisation (mCNV) and ...

Retinopathy of prematurity (ROP), a condition frequently seen in the premature infant, remains one of these challenges. Physiological stressors cause abnormal growth of retinal blood vessels and ...

Roper Technologies, Inc. designs and develops vertical software and technology enabled products in the United States, Canada, Europe, Asia, and internationally. It operates through three segments ...

Scleral buckling is the traditional method for correction of retinal detachment with ROP in Stage 4. Scleral buckling involves first treating the eye with cryotherapy or laser and then sewing a ...

New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to significantly greater reductions in albuminuria than either agent alone in ...

Ocular Surgery News OSN | Find ophthalmology news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.